Related content

Targeted therapy for non-small-cell lung cancer: past, present and future

By Forde Patrick M   Ettinger David S  

Expert Review of Anticancer Therapy, Vol. 13, Iss. 6, 2013-06 ,pp. : 745-758

Informa Healthcare

Access to resources Recommend Favorite

Small-cell lung cancer: where are we now and what can we expect for the future?

By Karachaliou Niki   Rosell Rafael  

Future Oncology, Vol. 9, Iss. 8, 2013-08 ,pp. : 1065-1068

Future Medicine

Access to resources Recommend Favorite

The role of mismatch repair in small-cell lung cancer cells

By Hansen L.T.   Thykjaer T.   Orntoft T.F.   Rasmussen L.J.   Keller P.   Spang-Thomsen M.   Bocker Edmonston T.   Schmutte C.   Fishel R.   Norgard Petersen L.  

European Journal of Cancer, Vol. 39, Iss. 10, 2003-07 ,pp. : 1456-1467

Elsevier

Access to resources Recommend Favorite

Irinotecan plus carboplatin in patients with extensive-disease small-cell lung cancer

By Kim Young  

Medical Oncology, Vol. 28, Iss. 1, 2011-03 ,pp. : 342-350

Humana Press, Inc

Access to resources Recommend Favorite

Time Factor in Radiotherapy and Chemotherapy for Limited Disease Small-Cell Lung Cancer

By Nowara Elzbieta   Suwinski Rafal  

Cancer Investigation, Vol. 25, Iss. 3, 2007-04 ,pp. : 163-171

Informa Healthcare

Access to resources Recommend Favorite